People · Operator
Named in public records as an officer, director or promoter · active 2011–2021 · Other, Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Visual Supply Co | — | Other | Series C | $90.0M | $857.3M | 2014 |
| Spire, Inc. | — | Other | Series B | $48.2M | $496.8M | 2020 |
| O2 Medtech Inc | — | Biotechnology | Seed | $7.1M | $160.3M | 2011 |
| Verve Medical, Inc. | — | Healthtech | Seed | $3.6M | $13.0M | 2014 |
Wayne Wu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Wayne Wu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Geoff Pardo | 1 | 6 |
| Ryan Sweeney | 1 | 5 |
| Shih-Ping (Bob) Wang | 1 | 4 |
| John Pavlidis | 1 | 4 |
| Steven Gex | 1 | 3 |
| Sean Cheng | 1 | 2 |
| Gordon Hull | 1 | 2 |
| Chris Raanes | 1 | 2 |
| Kevin Rooney | 1 | 2 |
| Christopher Raanes | 1 | 1 |
| Benjamin Yule | 1 | 1 |
| Jonathan Palley | 1 | 1 |
| Neema Moraveji | 1 | 1 |
| Chris Neil | 1 | 1 |
| Rtan Sweeney | 1 | 1 |
| Zengpin Yu | 1 | 1 |
| Paul Chan | 1 | 1 |
| Terry Buelna | 1 | 1 |
| Steve Gex | 1 | 1 |
| Greg Lutze | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.